AMPs have been shown to promote the apoptosis of tumor cells [27,28,29], and a melittin derivative (TT-1) was shown to stimulate caspase-3, caspase-9, and Bax expression and promote the apoptosis of human thyroid cancer cells (TT) following TT-1 treatment [29]. This evidence concerns the gene CASP9 and neoplasm.